Read More

Lykos to cut 75% of staff, reorganize in wake of FDA defeat

California-based Lykos Therapeutics announced a reorganization plan in the wake of the federal government’s rejection of its application for its MDMA-based drug designed to treat post-traumatic stress disorder. But the company promised stakeholders that the company is not giving up. Under the reorganization plan, Johnson & Johnson veteran executive Dr. …